Bildkälla: Stockfoto

Optomed: Expects full-year 2024 sales in line with 2023 - Redeye

Redeye comments on Optomed’s increased full-year outlook and changes our Q4 2024 sales estimate accordingly.

Redeye comments on Optomed’s increased full-year outlook and changes our Q4 2024 sales estimate accordingly.
Börsvärldens nyhetsbrev
ANNONSER